跳至主要内容
临床试验/CTRI/2021/05/033765
CTRI/2021/05/033765尚未招募未知

To study the effectiveness and safety of Prednisolone and Colchicine in comparison with Prednisolone alone in the treatment of moderate and severe Erythema Nodosum Leprosum: An open label randomized controlled trial

Dr Namrata Chhabra Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients with MB leprosy and older than 18 years with moderate and severe ENL (ENLIST ENL severity score ââ?°Â¥9) at the time of the OPD visit.

排除标准

  • 1.Absolute contraindications for steroids including hypersensitivity to drug or components of formulation, active tuberculosis, systemic fungal infection
  • 2.In group II, absolute contraindications of colchicine, i.e. patients with severe renal or hepatic dysfunction will be excluded
  • 3.Pregnant or breastfeeding women
  • 4.Individuals unable to attend regularly for assessment or monitoring

研究者

发起方
Dr Namrata Chhabra Sharma

相似试验